IRIS
IMAZIO, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.665
NA - Nord America 671
EU - Europa 468
SA - Sud America 451
AF - Africa 44
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.304
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 819
US - Stati Uniti d'America 633
BR - Brasile 356
CN - Cina 295
VN - Vietnam 179
IT - Italia 154
HK - Hong Kong 146
DE - Germania 71
IN - India 68
RU - Federazione Russa 68
KR - Corea 46
AR - Argentina 41
NL - Olanda 36
AT - Austria 25
EC - Ecuador 24
FI - Finlandia 20
JP - Giappone 20
FR - Francia 18
ID - Indonesia 18
GB - Regno Unito 16
MX - Messico 16
IE - Irlanda 15
BD - Bangladesh 13
ZA - Sudafrica 13
TR - Turchia 12
CA - Canada 11
PL - Polonia 10
SE - Svezia 10
PY - Paraguay 9
CL - Cile 8
KE - Kenya 8
IL - Israele 6
DO - Repubblica Dominicana 5
ES - Italia 5
IQ - Iraq 5
MA - Marocco 5
TG - Togo 5
SA - Arabia Saudita 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
CH - Svizzera 3
CO - Colombia 3
EG - Egitto 3
GR - Grecia 3
JO - Giordania 3
KZ - Kazakistan 3
LT - Lituania 3
PK - Pakistan 3
UA - Ucraina 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DM - Dominica 2
DZ - Algeria 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
PE - Perù 2
PH - Filippine 2
TN - Tunisia 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
BH - Bahrain 1
BW - Botswana 1
GY - Guiana 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
KW - Kuwait 1
LC - Santa Lucia 1
LV - Lettonia 1
MG - Madagascar 1
MZ - Mozambico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.304
Salva come PNG Salva come JPEG
Città #
Singapore 351
Hong Kong 144
Ashburn 143
Beijing 107
Ho Chi Minh City 75
Dallas 62
Los Angeles 55
Mumbai 49
Hefei 48
Seoul 46
Hanoi 37
Redondo Beach 30
Milan 29
Boardman 28
New York 28
São Paulo 27
Buffalo 26
Munich 25
Amsterdam 18
Tokyo 17
Vienna 17
Rio de Janeiro 15
Dublin 14
Nuremberg 13
Frankfurt am Main 12
Chandler 10
Stockholm 10
Curitiba 9
Düsseldorf 9
Guayaquil 9
Helsinki 9
North Bergen 9
Rome 9
Atlanta 8
Bologna 8
Johannesburg 8
Suzhou 8
Turin 8
Changsha 7
Chennai 7
Haiphong 7
Orem 7
Quito 7
Trieste 7
Brasília 6
Da Nang 6
Lappeenranta 6
Mexico City 6
Nairobi 6
Ogden 6
Porto Alegre 6
Santa Clara 6
Seattle 6
Thái Bình 6
Xi'an 6
Ankara 5
Brooklyn 5
Buenos Aires 5
Chengdu 5
Contagem 5
Fortaleza 5
Guarulhos 5
Houston 5
Hyderabad 5
Lomé 5
Mauá 5
St Petersburg 5
Warsaw 5
Biên Hòa 4
Chicago 4
Hải Dương 4
Lauterbourg 4
Naples 4
Padova 4
Riyadh 4
San Jose 4
Santo André 4
Tangshan 4
The Dalles 4
Thái Nguyên 4
Toronto 4
Uberlândia 4
Amman 3
Antalya 3
Astana 3
Athens 3
Baku 3
Bari 3
Belluno 3
Benito Juarez 3
Boston 3
Burlington 3
Bắc Giang 3
Campinas 3
Caxias do Sul 3
Charlotte 3
Corato 3
Cuenca 3
Cuiabá 3
Denver 3
Totale 1.813
Salva come PNG Salva come JPEG
Nome #
INFLA-score: A new diagnostic paradigm to identify pericarditis 89
Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging 88
[ANMCO Position paper: Care pathway for advanced heart failure patients candidate for heart transplantation/ventricular assist device] 85
Machine-learning tool for classifying pulmonary hypertension via expert reader-provided CT features: An educational resource for non-dedicated radiologists 79
New Developments in the Management of Recurrent Pericarditis 78
Colchicine in acute coronary syndromes: the present and the possible future 76
Asymptomatic Chronic Large Pericardial Effusions: To Drain or to Observe? 74
Diagnosis, Risk Stratification, and Treatment of Pericarditis: A Review 73
Leflunomide-induced pulmonary arterial hypertension: Case report and review of literature 72
Eosinophilic myocarditis: comprehensive update on pathophysiology, diagnosis, prognosis and management 72
Age-stratified patterns in clinical presentation, treatment and outcomes in acute pericarditis: a retrospective cohort study 71
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers 70
Colchicine for the treatment of the spectrum of cardiovascular diseases: Current evidence and ongoing perspectives 69
Persistence of fatigue in the absence of pathophysiological mechanisms in some patients more than 2 years after the original SARS-CoV-2 infection 69
Aortic pseudoaneurysm with a fistula between the non-coronary sinus and right atrium: a case report 68
ANMCO Position paper: Colchicine as a therapeutic agent in coronary syndromes 68
Efficacy of colchicine in addition to anakinra in patients with recurrent pericarditis 66
Distal Reoperations after Repair of Acute Type A Aortic Dissection—Incidence, Causes and Outcomes 64
Efficacy and safety of colchicine for the treatment of myopericarditis 63
Autoptic prevalence of pericarditis in coronavirus disease 2019 patients 62
Sustained Pericarditis Recurrence Risk Reduction With Long-Term Rilonacept 60
Management of cardiac sarcoidosis. A clinical consensus statement of the Heart Failure Association, the European Association of Cardiovascular Imaging, the ESC Working Group on Myocardial & Pericardial Diseases, and the European Heart Rhythm Association of the ESC 56
Update on the diagnosis and treatment of pericardial diseases: a position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseases 56
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 55
Duration of Disease and Long-Term Outcomes in Patients With Difficult-To-Treat Recurrent Pericarditis: A Chronic Condition Treated With Nonsteroidal Anti-Inflammatory Drugs, Colchicine, Corticosteroids, and Anti–Interleukin-1 Agents 55
Anakinra-Dependent Recurrent Pericarditis: The Role of the R202Q Variant of the MEFV Gene 54
Recurrent pericarditis in older adults: Clinical and laboratory features and outcome 54
The 2023 new European guidelines on infective endocarditis: Main novelties and implications for clinical practice 54
How to Use Interleukin-1 Antagonists in Patients With Pericarditis 53
Outcomes of acute pericarditis with an inflammatory phenotype 53
Pregnancy in patients with inherited myocardial disorders – A consensus document on preconception counseling and pregnancy management by the working group on myocardial and pericardial disorders of the Italian Society of Cardiology 52
Advancing our understanding of cardiac tumors 52
Post-cardiac injury syndrome and pericardial effusion recurrence after pericardial effusion drainage in chronic idiopathic pericardial effusion 52
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases 51
The impact of the European Society of Cardiology guidelines and whole exome sequencing on genetic testing in hereditary cardiac diseases 51
COVID-19 vaccines do not raise myocarditis and pericarditis incidence: Italian Society of Cardiology registry 50
Focus on 2023 ESC guidelines for the management of infective endocarditis: In light of new evidence 50
Critical approach to the 2023 European Society of Cardiology guidelines on cardiomyopathies: a document by the Working Group on Myocardial and Pericardial Diseases of the Italian Society of Cardiology 48
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 47
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 46
Unveiling the Spectrum of Pericardial Diseases: Insights, Novelties, and Future Directions 44
Risk Stratification of Recurrent Pericarditis: Hype or Hope? 43
Arrhythmic risk in acute myocarditis: Early threats, late events, and clinical uncertainty 43
Beyond the storm: rethinking recovery in fulminant myocarditis 43
Sudden cardiac death after acute myocarditis with arrhythmic presentation: Hunting for risk predictors - A systematic review and meta-analysis 42
Comparative Efficacy and Safety of Colchicine and Anti–Interleukin- 1 Agents in Recurrent Pericarditis: A Pairwise and Network Meta- Analysis of Randomized Controlled Trials 41
State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases 41
Medical therapy of pericarditis: Tips and tricks for clinical practice 40
Characteristics, Prognosis, and European Society of Cardiology and European Respiratory Society Risk Stratification in Patients With Obesity and Pulmonary Arterial Hypertension 40
Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 Blockade 40
When heart team really counts: Radical excision of intracardiac leiomyomatosis 40
Colchicine for prevention of major adverse cardiovascular events: A meta-analysis of randomized clinical trials 39
Inflammasome and ventricular arrhythmogenesis: Pathogenic interplay and potential targets on the horizon 38
Prevention of pericardial complications after cardiac surgery: Myth or reality? 38
Should we start using colchicine for secondary prevention of acute and chronic coronary syndromes after 2024 European society of cardiology guidelines? 37
One stage extraction and reimplantation of ICD/PM in patients with CIED related endocarditis and spondiloscitis due to E. faecalis treated with double beta-lactam combination: ampicillin plus ceftobiprole 36
Pericardial constrictive syndromes: a neglected cause of reversible heart failure 35
Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry 33
Risk of incident pericarditis after coronavirus disease 2019 recovery: a systematic review and meta-analysis 31
Myocarditis: an increasing global health challenge! 30
Scores for Risk Stratification of Pericarditis 28
On the Road to Disclose the Pathogenesis of Pericarditis 27
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: A report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of Cardiology 26
Colchicine for Cardiovascular Prevention: Clarity Amidst the Confusion 26
Prognostic role of genetic variants in recurrent pericarditis 25
Catheter ablation to prevent malignant ventricular arrhythmias in symptomatic Brugada syndrome: A systematic review and meta-analysis 21
The 2025 ESC myocarditis and pericarditis guidelines - what clinicians needs to know 13
Pericarditis at the crossroads: Unlocking the next wave of therapies 12
Comparative analysis of recurrence rates following various cessation strategies for rilonacept in recurrent pericarditis 11
Inflammatory cardiomyopathy: an update for clinicians 11
Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases 10
Efficacy and safety of colchicine for the treatment of myopericarditis 10
Myocarditis and pericarditis exercise recommendations: a critical review of 2023 COCIS recommendations 9
The top ten novelties of the ESC guidelines for the management of myocarditis and pericarditis 9
Change in prevalence of ATTR variants in Italy: Results from a national survey 5
Tolicizumab: a new option for refractory idiopathic recurrent pericarditis: a case report 3
Totale 3.525
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.520
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.520
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202343 0 0 0 9 7 9 0 3 2 1 9 3
2023/2024148 2 2 33 15 8 7 1 23 8 12 21 16
2024/20251.270 34 67 55 89 68 55 69 75 187 103 221 247
2025/20262.064 248 364 472 444 406 130 0 0 0 0 0 0
Totale 3.525